Subscribe to Newsletter

Standards & Regulation

Manufacture Standards & Regulation

Sticking to Your Stent

| James Strachan

New patient adherence tablet app incorporates storytelling and patient data.

Business & Regulation Business Practice

Business-in-Brief

| James Strachan

Bribery accusations, a new whistleblowing policy, and recalls... What’s new for pharma in business?

Business & Regulation Standards & Regulation

Catching Cargo Criminals

| Stephanie Vine

How does the FBI track down culprits of pharma heists?

Manufacture Business Practice

Hopping Aboard the Darjeeling Limited

| Dev Ohri

India has held pharma’s interest for decades, but it is a challening market to work in.

Business & Regulation Standards & Regulation

Mutual Respect

| James Strachan

FDA and EMA forge an agreement to mutually recognize drug manufacturing inspections.

Business & Regulation Ingredients

Meeting Mark Paxton

| Mark Paxton

Mark Paxton was appointed CEO of Rx-360 in 2015. Here, he discusses the journey so far

Manufacture Ingredients

Global Vigilance

| Martin VanTrieste

Martin Van Trieste tells the emotional story behind the creation of Rx-360

Business & Regulation Biosimilars

Russian Revolution for Biosimilars

| Roman Ivanov

Could manufacturers based in Russia be well placed to develop cheaper biopharmaceuticals?

Business & Regulation Business Practice

Breaking with Tradition

| Joanna Cummings

What does the legalization of medical cannabis mean for conventional pharmaceuticals?

Manufacture Standards & Regulation

Testing the Water

| James Strachan

Pharma is urged to tackle the problem of polluted waste water from manufacturing plants.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register